Santen Pharmaceutical: Announcements of individual stocks regarding the disposal of treasury stocks based on stock-linked compensation program.
Santen Pharmaceutical: Santen announces the status of its stock buyback
Santen Pharmaceutical: Independent Officer Notification Form
Santen Pharmaceutical: Notice regarding the recording of impairment losses and financial asset valuation losses
Santen Pharmaceutical: Notice regarding the recording of impairment losses and valuation losses on financial assets
Santen Pharmaceutical: Santen announces share buyback
Santen Pharmaceutical: Santen will report consolidated financial results for fiscal year 2023
Santen Pharmaceutical: Notice regarding cancellation of treasury stock
Santen Pharmaceutical: Santen announces change of representative director of the board
Santen Pharmaceutical: Santen announces cancellation of treasury stock
Santen Pharmaceutical: Santen announces completion of share repurchase
Santen Pharmaceutical: Santen announces stock buyback status
Santen Pharmaceutical: Revision of Dividend Forecast
Santen Pharmaceutical: Santen Reports the 3rd Quarter Fiscal 2023 Consolidated Performance
Santen Pharmaceutical: Santen Announces Status of Share Buyback
Santen Pharmaceutical: Santen Announces Status of Share Buyback
Santen Pharmaceutical: Corporate Governance Report
Santen Pharmaceutical: Santen Announces Status of Share Buyback
Santen Pharmaceutical: Santen Reports the 2nd Quarter Fiscal 2023 Consolidated Performance
Santen Pharmaceutical: Santen Announces Status of Share Buyback
No Data